Morgan Stanley’s Tourmaline Bio TRML Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.8M | Buy |
362,736
+76,991
| +27% | +$1.23M | ﹤0.01% | 3938 |
|
|
2025
Q1 | $4.35M | Buy |
285,745
+81,463
| +40% | +$1.24M | ﹤0.01% | 4043 |
|
|
2024
Q4 | $4.14M | Sell |
204,282
-33,467
| -14% | -$679K | ﹤0.01% | 4157 |
|
|
2024
Q3 | $6.11M | Sell |
237,749
-90,193
| -28% | -$2.32M | ﹤0.01% | 3816 |
|
|
2024
Q2 | $4.22M | Buy |
327,942
+311,623
| +1,910% | +$4.01M | ﹤0.01% | 4026 |
|
|
2024
Q1 | $374K | Buy |
16,319
+3,971
| +32% | +$90.9K | ﹤0.01% | 5443 |
|
|
2023
Q4 | $323K | Buy |
12,348
+8,728
| +241% | +$229K | ﹤0.01% | 5770 |
|
|
2023
Q3 | $102K | Sell |
3,620
-1,220
| -25% | -$34.3K | ﹤0.01% | 5885 |
|
|
2023
Q2 | $147K | Sell |
4,840
-22,624
| -82% | -$688K | ﹤0.01% | 5773 |
|
|
2023
Q1 | $516K | Buy |
27,464
+26,130
| +1,959% | +$491K | ﹤0.01% | 5237 |
|
|
2022
Q4 | $13.6K | Sell |
1,334
-585
| -30% | -$5.97K | ﹤0.01% | 6829 |
|
|
2022
Q3 | $51K | Sell |
1,919
-351
| -15% | -$9.33K | ﹤0.01% | 6397 |
|
|
2022
Q2 | $103K | Sell |
2,270
-1,152
| -34% | -$52.3K | ﹤0.01% | 6264 |
|
|
2022
Q1 | $337K | Buy |
3,422
+75
| +2% | +$7.39K | ﹤0.01% | 5618 |
|
|
2021
Q4 | $511K | Buy |
3,347
+962
| +40% | +$147K | ﹤0.01% | 5528 |
|
|
2021
Q3 | $323K | Buy |
2,385
+560
| +31% | +$75.8K | ﹤0.01% | 5742 |
|
|
2021
Q2 | $269K | Buy |
+1,825
| New | +$269K | ﹤0.01% | 5867 |
|